Indication
African Trypanosomiasis
3 clinical trials
3 products
1 drug
Clinical trial
An Open-label Study Assessing Effectiveness, Safety and Compliance With Fexinidazole in Patients With Human African Trypanosomiasis Due to T.b. Gambiense at Any StageStatus: Completed, Estimated PCD: 2021-02-01
Product
FexinidazoleClinical trial
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Non-parasitologically Confirmed Subjects: a Multicentre Randomised Double-blind Placebo-controlled StudyStatus: Completed, Estimated PCD: 2023-08-02
Product
AcoziboroleDrug
VarlilumabClinical trial
An Intervention Study to Evaluate the Impact of Treating gHAT Seropositive Subjects With Acoziborole on Transmission of T.b. Gambiense, and Obtain Further Safety Data on Acoziborole in gHAT Seropositive IndividualsStatus: Not yet recruiting, Estimated PCD: 2026-12-30